NIKKEI 225
36,876.46 -1,203.24 (-3.16%) HANG SENG
16,169.52 -216.35 (-1.32%) CRUDE OIL
85.36 +2.63 (+3.18%) GOLD FUTURES
2,423.40 +25.40 (+1.06%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
49,323.43 -468.25 (-0.94%)
Pfizer Inc. (PFE)
After hours:
| Previous close | 25.42 |
| Open | 25.35 |
| Bid | 25.30 x 4000 |
| Ask | 25.40 x 1400 |
| Day's range | 25.23 - 25.46 |
| 52-week range | 25.23 - 40.37 |
| Volume | |
| Avg. volume | 42,898,575 |
| Market cap | 143.772B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 68.62 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.68 (6.61%) |
| Ex-dividend date | 25 Jan 2024 |
| 1y target est | N/A |
- Investor's Business Daily
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?
- Fool.co.uk
2 dividend growth shares I’ve just bought for my Stocks and Shares ISA
Stephen Wright's been looking beyond the UK for dividend shares in the last couple of weeks. Here are the opportunities he thinks are too good to miss. The post 2 dividend growth shares I’ve just bought for my Stocks and Shares ISA appeared first on The Motley Fool UK.
- Benzinga
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost in line with estimates. First quarter results came shortly after JNJ’s expansion in the cardiovascular space with the $13.1 billion acquisition of heart device firm Shockwave Medical Inc (NASDAQ: SWAV). First Quarter Highlights For the period ended in March, the healthcare company posted a revenue
